Spots Global Cancer Trial Database for lung cancer stage ii
Every month we try and update this database with for lung cancer stage ii cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy | NCT04305613 | Cardiotoxicity Lung Cancer Sta... Lung Cancer Sta... Radiation Toxic... | Chemoradiation | 18 Years - | Abramson Cancer Center at Penn Medicine | |
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating | NCT03322072 | Lung Cancer Sta... Lung Cancer Sta... Lung Cancer, No... Lung Cancer Rec... Lung Cancer Sta... | Real-Time Posit... | 18 Years - 85 Years | CancerCare Manitoba | |
Accelerated Pulmonary Rehabilitation in the Preoperative Period | NCT06432972 | Chronic Obstruc... Lung Cancer Sta... Lung Cancer Sta... Lung Cancer Sta... | Pulmonary Rehab | 18 Years - | University of Vermont | |
Accelerated Pulmonary Rehabilitation in the Preoperative Period | NCT06432972 | Chronic Obstruc... Lung Cancer Sta... Lung Cancer Sta... Lung Cancer Sta... | Pulmonary Rehab | 18 Years - | University of Vermont | |
COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA) | NCT05258448 | Cardiac Toxicit... Lung Cancer Sta... Lung Cancer Sta... Radiation Toxic... Cardiac Disease | Chemoradiothera... | 18 Years - | Odense University Hospital | |
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating | NCT03322072 | Lung Cancer Sta... Lung Cancer Sta... Lung Cancer, No... Lung Cancer Rec... Lung Cancer Sta... | Real-Time Posit... | 18 Years - 85 Years | CancerCare Manitoba | |
Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC Treatment | NCT04970043 | Lung Cancer Sta... | Camrelizumab+ p... | 18 Years - 70 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis | NCT03984019 | Lung Cancer Sta... Lung Cancer Sta... Lung Metastases | Cardiac conditi... | 18 Years - | The Netherlands Cancer Institute | |
Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC | NCT03141359 | Lung Cancer Sta... Lung Cancer Sta... Non Small Cell ... | SBRT Carboplatin Paclitaxel cis Platinum Etoposide IMRT Durvalumab | 18 Years - | Wake Forest University Health Sciences | |
Avecure Flexible Microwave Ablation Probe For Lung Nodules | NCT05281237 | Stage I - II Pr... Stage I Lung Ca... Stage II Lung C... Lung Cancer Sta... Lung Cancer Sta... Lung Cancer | AveCure 16 Gaug... | 22 Years - | Beth Israel Deaconess Medical Center | |
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery | NCT04991025 | Lung Cancer Lung Cancer Sta... Lung Cancer Sta... | Cisplatin Pemetrexed Gemcitabine Carboplatin Certolizumab Nivolumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Accelerated Pulmonary Rehabilitation in the Preoperative Period | NCT06432972 | Chronic Obstruc... Lung Cancer Sta... Lung Cancer Sta... Lung Cancer Sta... | Pulmonary Rehab | 18 Years - | University of Vermont | |
Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II | NCT04375566 | Lung Cancer Sta... Lung Cancer Sta... | Patient Decisio... | 21 Years - 100 Years | Maastricht University | |
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery | NCT04991025 | Lung Cancer Lung Cancer Sta... Lung Cancer Sta... | Cisplatin Pemetrexed Gemcitabine Carboplatin Certolizumab Nivolumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy | NCT04305613 | Cardiotoxicity Lung Cancer Sta... Lung Cancer Sta... Radiation Toxic... | Chemoradiation | 18 Years - | Abramson Cancer Center at Penn Medicine | |
A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC | NCT04108013 | Lung Cancer Sta... PD-1 Antibody Non-small Cell ... | SHR-1210 Carboplatin and... | 18 Years - 70 Years | Xuanwu Hospital, Beijing |